Total Return chart Filana Therapeutics, Inc.

Stocks

Market Closed - Nasdaq 00:00:00 30/10/2026 +04			5-day change	1st Jan Change
0.6580 ^USD	+1.12%		+0.60%	-66.77%

10-28	Filana Therapeutics, Inc. Announces Publication Of Promising Preclinical Findings For Simufilam In TSC2-Deficient Cells	CI
10-01	Filana Therapeutics Insider Bought Shares Worth $278,132, According to a Recent SEC Filing	MT

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.

13/12/2012	0.75 USD
13/12/2010	2 USD